Abstract
Objective:
Red blood cell (RBC) transfusions can suppress erythropoiesis. On this basis, RBC transfusions administered to very low birth weight (VLBW) neonates potentially render them more likely to qualify for a subsequent transfusion.
Study Design:
We hypothesized that ‘late’ (>14 days after birth) RBC transfusions given to VLBW neonates result in a decrease in reticulocyte count persisting for at least 7 to 10 days. We also hypothesized that a single dose of darbepoetin given along with the transfusion would have the opposite effect, increasing the reticulocyte count for at least 7 to 10 days. To test this, we conducted a single-centered randomized trial with 20 VLBW neonates who, according to our transfusion guidelines, qualified for a late transfusion.
Result:
VLBW infants about to receive a late RBC transfusion were randomized (1:1) to also receive vs not receive (controls) a single subcutaneous dose of darbepoetin (10 μg kg−1). Reticulocyte counts diminished significantly in the controls (a drop of 85±62 × 103 μl−1 (mean±s.d.) at 7 to 10 days), but increased significantly in the darbepoetin recipients (an increase of 177±120 × 103 μl−1 at 7 to 10 days, P<0.0001). At 7 to 10 days after the transfusion, hematocrits of the controls were 8.1±4.9 points above their pre-transfusion values and of the darbepoetin group were 12.4±2.7 points above their pre-transfusion values (P=0.033).
Conclusion:
This was a limited-scope, single-centered, randomized trial intended to pilot-test a new concept in neonatal transfusion practice. Namely, we tested whether a late RBC transfusion suppressed reticulocytosis and whether a concomitant single dose of darbepoetin counteracted that suppression. Using the pilot data presented in this study, larger trials can now be designed to address meaningful clinical outcomes such as transfusion avoidance using this approach.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Luban NLC . Transfusion of blood and blood products. In: MacDonald and Ramasethu (eds). Atlas of Procedures in Neonatology, 4th edn. Lippincott/Williams & Wilkins: Philadelphia, 2007, pp 317–328.
New HV, Stanworth SJ, Engelfriet CP, Reesink HW, McQuilten ZK, Savoia HF et al. Neonatal transfusions. Vox Sang 2009; 96: 62–85.
Strauss RG . How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion 2008; 48: 209–217.
Murray NA, Roberts IAG . Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: 101–107.
Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G . Transfusion medicine and safety. Biologicals 2009; 37: 62–70.
Stainsby D, Faber J-C, Jorgensen J . Overview of hemovigilance. In: Simon TL, Soleihm BG, Strauss RG, Snyder EL, Petrides M (eds). Rossi's Principles of Transfusion Medicine, 4th edn. Wiley-Blackwell: Bethesda, MD, 2009, pp 683–698.
Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney JA et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. Pediatrics 1990; 117: 447–454.
Wulff H, Wichmann HE, Pantel K, Loeffler M . A mathematical model of erythropoiesis in mice and rats. Part 3: Suppressed erythropoiesis. Cell Tissue Kinet 1989; 22: 51–61.
Wiktor-Jedrzejczak W . Erythropoietic stimulation enhances, and erythropoietic inhibition suppresses, multidirectional differentiation in 4-day transient endogenous spleen colonies. Experientia 1981; 37: 1024–1026.
Jelkmann W . Effects of erythropoietin on brain function. Curr Pharm Biotechnol 2005; 6: 65–79.
McPherson RJ, Juul SE . Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010; 22: 139–145.
Bierer R, Peceny MC, Hartenberger CH, Ohls RK . Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006; 118: e635–e640.
Testa U . Erythropoietic stimulating agents. Exopert Opin Emerg Drugs 2010; 15: 119–138.
Song S, Long SR, Marder WE, Sullivan SD, Kallich J . The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother 2009; 43: 1203–1210.
Warwood TL, Ohls RK, Lambert DK, Jones C, Scoffield SH, Gupta N et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006; 26: 296–300.
Warwood TL, Ohls RK, Lambert DK, Leve EA, Veng-Pedersen P, Christensen RD . Urinary excretion of darbepoetin after intravenous vs. subcutaneous administration to preterm neonates. J Perinatol 2006; 26: 636–639.
Warwood TL, Ohls RD, Wiedmeier SE, Lambert DK, Jones C, Scoffield SH et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 2008; 25: 725–730.
Freise JK, Widness JA, Veng-Pedersen P . Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. J Pharmacol Exp Ther 2010; 332: 229–237.
Baer VL, Lambert DK, Schmutz N, Henry E, Stoddard RA, Miner C et al. Adherence to NICU transfusion guidelines: data from a multihospital healthcare system. J Perinatol 2008; 28: 492–497.
Widness JA . Treatment and prevention of neonatal anemia. Neoreviews 2008; 9: 526–533.
Crowley M, Kirpalani H . A rational approach to red blood cell transfusion in the neonatal ICU. Curr Opin Pediatr 2010; 22: 151–157.
Strauss RG . Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 2000; 40: 1528–1540.
Litty CA . Neonatal red cell transfusions. Immunohematology 2008; 24: 10–14.
Valieva OA, Thomas P, Mayock DE, Juul SE . Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr 2009; 155: 331–337.
Sanchez R, Toy P . Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 2005; 45: 248–255.
Christensen RD, Lambert DK, Henry E, Wiedmeier SE, Snow GL, Baer VL, et al. Is ‘transfusion-associated necrotizing enterocolitis’ an authentic pathogenic entity? Transfusion 2010; 50: 1106–1112.
Rühl H, Bein G, Sachs UJ . Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009; 23: 62–71.
Wardrop CAJ, Holland BM, Veale KEA, Jones JG, Gray OP . Nonphysiological anemia of prematurity. Arch Dis Child 1978; 53: 855–860.
Stockman III JA, Garcia JF, Oski FA . The anemia of prematurity. Factors governing the erythropoietin response. N Engl J Med 1977; 296: 647–650.
Acknowledgements
We thank Nancy Schmutz, RN, for her assistance with the Institutional Review Board application, and Scott Scoffield, PharmD, of the Pharmacy Department and the NICU nursing staff at the McKay-Dee Hospital Center for their valuable assistance in conducting this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Warwood, T., Lambert, D., Henry, E. et al. Very low birth weight infants qualifying for a ‘late’ erythrocyte transfusion: Does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?. J Perinatol 31 (Suppl 1), S17–S21 (2011). https://doi.org/10.1038/jp.2010.165
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.165
Keywords
This article is cited by
-
Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?
Journal of Perinatology (2015)